Latest news

Latest news, scientific publications and events

Diabetes

SUDOSCAN at the EASD Annual Meeting 2022

Meet Impeto Medicalat the EASD Annual Meeting 2022 Impeto Medical is pleased to announce its participation from the 19th to the 23rd of september 2022 …

September 2, 2022
JNC-Congress-2022
Events

SUDOSCAN at the 5th JNC Congress 2022

SUDOSCAN at the “5ème Journées de Neurophysiologie Clinique” the 29 of June to the 1st of July 2022 Impeto Medical will attend and participate to …

May 21, 2022
Events

SUDOSCAN at the EAN Congress 2022

SUDOSCAN at the EAN Congress25-28 of June 2022   Impeto Medical participates with SUDOSCAN to the European Academy of Neurology (EAN) Congress the 25-28 of …

May 20, 2022

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

To receive our latest scientific news:

Website dedicated
to health professionals

I am a health professional

Scroll to Top